The therapeutic management of psoriasis includes conventional treatments as well as the new generation of highly effective TNF-α inhibitors. However, psoriasis has proven to be a complex therapeutic challenge and treatment failures are not uncommon. Thus, laboratory biomarkers of disease progression/therapeutic efficacy may greatly help in the clinical management of psoriasis.
Cordiali Fei, P., Bianchi, L., Bonifati, C., Trento, E., Ruzzetti, M., Francesconi, F., et al. (2014). Immunologic biomarkers for clinical and therapeutic management of psoriasis. MEDIATORS OF INFLAMMATION, 2014 [10.1155/2014/236060].
Immunologic biomarkers for clinical and therapeutic management of psoriasis
BIANCHI, LUCA;CHIRICOZZI, ANDREA;CAMPIONE, ELENA;ORLANDI, AUGUSTO;CHIMENTI, SERGIO;
2014-01-01
Abstract
The therapeutic management of psoriasis includes conventional treatments as well as the new generation of highly effective TNF-α inhibitors. However, psoriasis has proven to be a complex therapeutic challenge and treatment failures are not uncommon. Thus, laboratory biomarkers of disease progression/therapeutic efficacy may greatly help in the clinical management of psoriasis.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Mediators of Inflammation.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Licenza:
Copyright dell'editore
Dimensione
968.47 kB
Formato
Adobe PDF
|
968.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
